Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Keyla C. S. Gonçalves"'
Autor:
Vanessa V. S. Castilho, Keyla C. S. Gonçalves, Karina M. Rebello, Luiz P. R. Baptista, Leandro S. Sangenito, Helena L. C. Santos, Marta H. Branquinha, André L. S. Santos, Rubem F. S. Menna-Barreto, Ana C. Guimarães, Claudia M. d’Avila-Levy
Publikováno v:
BMC Research Notes, Vol 11, Iss 1, Pp 1-7 (2018)
Abstract Objective The low investment in research, diagnosis and treatment are factors that contribute to the continuity of Chagas’ disease as a neglected tropical diseases (NTDs). In this context, the repositioning of drugs represents a useful str
Externí odkaz:
https://doaj.org/article/c560487b46cd4b1ca0aa19cd35e294d3
Autor:
Fernanda A Marinho, Keyla C S Gonçalves, Simone S C Oliveira, Diego S Gonçalves, Filipe P Matteoli, Sergio H Seabra, Ana Carolina S Oliveira, Maria Bellio, Selma S Oliveira, Thaïs Souto-Padrón, Claudia M d'Avila-Levy, André L S Santos, Marta H Branquinha
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e87659 (2014)
Human cutaneous leishmaniasis is caused by distinct species, including Leishmania amazonensis. Treatment of cutaneous leishmaniasis is far from satisfactory due to increases in drug resistance and relapses, and toxicity of compounds to the host. As a
Externí odkaz:
https://doaj.org/article/9c7bdc12e1df4bd9abdf9e753b3afd5d
Autor:
Claudia M. d’Avila-Levy, Helena Santos, Rubem F. S. Menna-Barreto, Keyla C. S. Gonçalves, André L.S. Santos, Vanessa V. S. Castilho, Marta H. Branquinha, Karina M. Rebello, Luiz Phillippe R. Baptista, Leandro S. Sangenito, Ana Carolina Ramos Guimarães
Publikováno v:
BMC Research Notes
BMC Research Notes, Vol 11, Iss 1, Pp 1-7 (2018)
BMC Research Notes, Vol 11, Iss 1, Pp 1-7 (2018)
Objective The low investment in research, diagnosis and treatment are factors that contribute to the continuity of Chagas’ disease as a neglected tropical diseases (NTDs). In this context, the repositioning of drugs represents a useful strategy, in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6ad0b0a215eacafc3019353cedd11e5
https://pubmed.ncbi.nlm.nih.gov/30463602
https://pubmed.ncbi.nlm.nih.gov/30463602
Autor:
Fernanda A. Marinho, Keyla C. S. Gonçalves, Marta H. Branquinha, Maria Bellio, Selma Soares de Oliveira, Claudia M. d’Avila-Levy, André L.S. Santos, Ana Carolina Oliveira
Publikováno v:
Memórias do Instituto Oswaldo Cruz, Volume: 106, Issue: 4, Pages: 507-509, Published: JUN 2011
Memórias do Instituto Oswaldo Cruz., Vol 106, Iss 4, Pp 507-509 (2011)
Memórias do Instituto Oswaldo Cruz., Vol 106, Iss 4, Pp 507-509 (2011)
In the current study, we evaluated the mechanism of action of miltefosine, which is the first effective and safe oral treatment for visceral leishmaniasis, in Leishmania amazonensis promastigotes. Miltefosine induced a process of programmed cell deat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74b2b90c008e1246dd80df0f49be1ddd
https://doi.org/10.1590/s0074-02762011000400021
https://doi.org/10.1590/s0074-02762011000400021
Autor:
Claudia M. d’Avila-Levy, Simone S.C. Oliveira, Maria Bellio, Diego de Souza Gonçalves, Filipe P. Matteoli, Keyla C. S. Gonçalves, Thaïs Souto-Padrón, Marta H. Branquinha, André L.S. Santos, Ana Carolina Oliveira, Sergio H. Seabra, Fernanda A. Marinho, Selma Soares de Oliveira
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 1, p e87659 (2014)
PLoS ONE, Vol 9, Iss 1, p e87659 (2014)
Background Human cutaneous leishmaniasis is caused by distinct species, including Leishmania amazonensis. Treatment of cutaneous leishmaniasis is far from satisfactory due to increases in drug resistance and relapses, and toxicity of compounds to the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7e7bf9c7f13929205a36956d4d5bec5
http://europepmc.org/articles/PMC3909198
http://europepmc.org/articles/PMC3909198
Autor:
Claudia M. d’Avila-Levy, Simone S.C. Oliveira, André L.S. Santos, Vítor Ennes-Vidal, Marta H. Branquinha, Keyla C. S. Gonçalves, Leandro S. Sangenito, Fernanda A. Marinho
Publikováno v:
Current Medicinal Chemistry
The treatment for both leishmaniasis and trypanosomiasis, which are severe human infections caused by trypanosomatids belonging to Leishmania and Trypanosoma genera, respectively, is extremely limited because of concerns of toxicity and efficacy with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76ccef0248fa0ff96cb4ec8f3fefce3b
https://pubmed.ncbi.nlm.nih.gov/23899207
https://pubmed.ncbi.nlm.nih.gov/23899207